AstraZeneca
AZN
#49
Rank
C$391.56 B
Marketcap
C$126.29
Share price
0.19%
Change (1 day)
24.93%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): C$4.27

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is C$4.13. In 2024 the company made an earnings per share (EPS) of C$3.09 an increase over its 2023 EPS that were of C$2.61.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$4.2738.03%
2024C$3.0918.23%
2023C$2.6181.13%
2022C$1.44631.03%
2021C$0.20-88.11%
2020C$1.66136.89%
2019C$0.70-39.41%
2018C$1.16-28.27%
2017C$1.61-14.37%
2016C$1.8824.11%
2015C$1.52127.55%
2014C$0.67-51.96%
2013C$1.39-58.95%
2012C$3.38-32.2%
2011C$4.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$14.21 243.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$10.02 142.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$2.34-43.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$10.97 165.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$27.93 576.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$5.04 22.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$14.96 262.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.34 150.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.04-2.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.90 18.48%๐Ÿ‡ฌ๐Ÿ‡ง UK